Well Pharmacy
Private and voluntary organisations · Company
First report 12 Oct 2017•Latest report 12 Oct 2017
Reports, concerns and published responses
Reports over time
Reports naming this recipient by issue year.
* 2026 is projected from reports observed to 7 Sep 2026.
- Reports
- 1
- Published responses
- 0%
- Concerns addressed
- 0
- Stated actions
- 0
Naming this recipient
Found for named reports
Across all linked responses
Described in responses
Concerns and recipient responses
Statements from Well Pharmacy linked to the concerns in each report. Select any concern, action or position to view the source wording.
-
Concerns raised3
Failure to ensure continuation of prescription safety controls after trial completion
Lack of communication of clinical urgency when prescriptions are downloaded
Inaccurate help information about unavailable prescription urgency functionality
No linked response statementsNo action or position from this recipient is clearly linked to the concerns in this report.
Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations
Data last updated 7 September 2026